Dr Reddys Laboratories Share Price Today - Live Blog for November 24, 2025

Dr Reddys Laboratories Ltd's shares saw an increase of 0.35%, reaching the current market price of ₹1,224.75. This development underscores the stock's growing popularity.

Dr Reddys Laboratories Ltd's share price has fallen by -0.04%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,225.70, and market participants are assessing the implications. The stock has a PE ratio of 18.1100, an ROE of 16.0277% and a debt to equity ratio of 0.1625.

With a -0.47% decrease, Dr Reddys Laboratories Ltd's share price is now at ₹1,226.15. The stock is currently trading at a PE of 18.1100, while the industry PE is 33.0081, prompting investors to assess its value proposition.

Dr Reddys Laboratories Ltd witnessed a -0.14% decrease in its share price, and it is currently trading at ₹1,231.70. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 18.1100, an ROE of 16.0277% and a debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd share price surged by 0.13%. With its current market price standing at ₹1,233.45 per share, this stock is garnering increased attention from the investment community.

The stock of Dr Reddys Laboratories Ltd has experienced a -0.05% drop, and it's now trading at ₹1,231.85 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

Dr Reddys Laboratories Ltd witnessed a -0.44% decrease in its share price, and it is currently trading at ₹1,232.50. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 18.1100, an ROE of 16.0277% and a debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd stock price decreased by -0.44%, with the current market value at ₹1,232.50 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

Dr Reddys Laboratories Ltd shares saw a -0.04% decrease, reaching a current market price of ₹1,238.75. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 18.1100, an ROE of 16.0277% and a debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd's share price has fallen by -0.05%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,239.30, and market participants are assessing the implications. The stock has a PE ratio of 18.1100, an ROE of 16.0277% and a debt to equity ratio of 0.1625.

In recent times, Dr Reddys Laboratories Ltd witnessed a decline of -0.14% in its share price, and it currently trades at ₹1,240.85 per share. The stock has an ROE of 16.0277% and debt to equity ratio of 0.1625.

The stock of Dr Reddys Laboratories Ltd is facing a -0.02% decline and is currently trading at ₹1,242.00 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

Dr Reddys Laboratories Ltd's share price has fallen by -0.18%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,242.40, and market participants are assessing the implications. The stock has a PE ratio of 18.1100, an ROE of 16.0277% and a debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd share price has declined by -0.24%, and it's currently trading at ₹1,245.00. The stock maintains a PE of 18.1100, while the industry PE is 33.0081, prompting discussions about its valuation.

The share price of Dr Reddys Laboratories Ltd plunged by -0.24%, leaving investors concerned. At this moment, the stock can be acquired at ₹1,248.00, but investors are assessing whether this is a temporary dip or a long-term trend.

After a significant 0.03% gain, Dr Reddys Laboratories Ltd's shares are now valued at ₹1,250.40 in the current market. This upward movement is attracting attention from both retail and institutional investors.

Dr Reddys Laboratories Ltd witnessed a substantial 0.00% increase in its share price and is currently trading at ₹1,250.05. This remarkable performance has caught the eye of investors.

The stock of Dr Reddys Laboratories Ltd suffered a -0.37% drop, and it's now trading at ₹1,252.00 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

The stock of Dr Reddys Laboratories Ltd is facing a -0.09% decline and is currently trading at ₹1,258.20 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

After a -0.03% decline, Dr Reddys Laboratories Ltd shares are now trading at ₹1,259.55. The stock has a PE ratio of 18.1100, an ROE of 16.0277% and a debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd's stock has surged by 0.35%, and it is currently trading at ₹1,260.60. Additionally, the stock maintains a PE ratio of 18.1100, while the industry PE is 33.0081.

The share price of Dr Reddys Laboratories Ltd soared by an impressive 0.30%, marking a substantial gain for investors. At present, this stock can be acquired at a current market price of ₹1,257.80 per share.

The share price of Dr Reddys Laboratories Ltd experienced an uptrend, surging by 0.30% recently. As of now, this stock is actively trading at a current market price of ₹1,257.80 per share, attracting attention from investors.

The share price of Dr Reddys Laboratories Ltd recently experienced a positive upturn, resulting in a 0.40% increase. Presently, it is actively trading at ₹1,256.05.

The share price of Dr Reddys Laboratories Ltd experienced an impressive 0.27% upswing and is currently trading at ₹1,251.40, indicating strong market sentiment.

After a -0.19% decline, Dr Reddys Laboratories Ltd shares are now trading at ₹1,248.00. The stock has a PE ratio of 18.1100, an ROE of 16.0277% and a debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd's share price has experienced a notable 1.71% upswing, and it's currently trading at ₹1,246.00 per share. Investors are closely watching this development.